Old Drugs, New Uses: Solving a Hatch-Waxman Patent Predicament
Author
McPhie, David C.
Metadata
Show full item recordCitation
Old Drugs, New Uses: Solving a Hatch-Waxman Patent Predicament (2003 Third Year Paper)Abstract
In early 2003, two panels of the Federal Circuit clashed in a pair of cases (Warner-Lambert v. Apotex and Allergan v. Alcon) dealing with the question of whether an action for inducement of infringement could be leveled against a generic drug manufacturer seeking FDA approval for an unpatented drug with both patented and unpatented uses. This paper takes up this debate, analyzing the interpretive puzzles presented in the application of the intricate Hatch-Waxman Act to this set of facts, arguing that the correct interpretation weaves elements from both panels’ approaches. It finishes with an alternative solution borrowed from a lesson in copyright.Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:8852107
Collections
- HLS Student Papers [498]
Contact administrator regarding this item (to report mistakes or request changes)